Studies on Smoking Genes and Transcriptional Control of Chronic Fatigue Syndrome Revealed in Molecular Medicine
Smokers who have an easier time quitting may have the benefit of specific genes that can foster success, according to a new study by a team of federal scientists at the National Institute on Drug Abuse.
The authors did not find genetic linkage in social smokers (people who smoked at low and steady levels but who were not dependent on cigarettes).
These findings are "reassuring for future attempts to use genotype-based data to match smokers with the type and/or intensities of treatments that provide the best and most cost-effective smoking cessation opportunities for them in community settings," the authors wrote.
Other studies in the January-February 2009 issue of Molecular Medicine include ''Transcriptional Control of Chronic Fatigue Syndrome'' and ''Human AM/AMBP1 as a Treatment for Sepsis.''
Molecular Medicine is published by The Feinstein Institute for Medical Research, part of the North Shore-LIJ Health System. To read the journal online and view this month's popular podcast go to www.molmed.org. For more information contact Assistant Editor, Veronica Davis at 516-562-2670.